SCHEMBL10196089

SCHEMBL10196089

CCc1ccc(Oc2cnc3cc(Cl)ccc3n2)cc1C1=C(O)CCC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
CYP1A2 P05177 3/20 0.42
CYP3A4 P08684 3/20 0.42
LMNA P02545 2/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HPGD P15428 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
TP53 P04637 1/20 0.42
ALOX15 P16050 1/20 0.42
NFKB1 P19838 1/20 0.42
HIF1A Q16665 1/20 0.42
GMNN O75496 1/20 0.42
APEX1 P27695 1/20 0.42
PMP22 Q01453 1/20 0.42
CYP2C19 P33261 2/20 0.39
CYP2C9 P11712 1/20 0.39
HTT P42858 7/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HRH4 Q9H3N8 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10196225 0.89 HTT (0.39) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL10196213 0.88 HTT (0.44) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL10195186 0.87 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL13190201 0.87 CYP1A2 (0.39) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL10196170 0.87 PDE4B (0.34) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL10196236 0.85 ALDH1A1 (0.34) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL10195400 0.83 CYP1A2 (0.37) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL10255136 0.81 CYP1A2 (0.39) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL10196017 0.81 CYP1A2 (0.39) ALDH1A1CYP1A2CYP3A4LMNAMAPT
SCHEMBL10195450 0.81 CYP1A2 (0.39) ALDH1A1CYP1A2CYP3A4LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2389066-B1 CYCLOPENTADIONE DERIVED HERBICIDES SYNGENTA LTD (GB) 2017-07-05 EP disclosed
US-8895474-B2 Herbicidally active cyclopentanediones and derivatives thereof, and their use in controlling weeds SYNGENTA LIMITED (GB) 2014-11-25 US disclosed
US-8895474-B2 Herbicidally active cyclopentanediones and derivatives thereof, and their use in controlling weeds SYNGENTA LIMITED (GB) 2014-11-25 US disclosed
US-20120021912-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
US-20120021912-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010102848-A1 CYCLOPENTADIONE DERIVED HERBICIDES SYNGENTA LIMITED (GB) 2010-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120021912-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 ALDH1A1 14/4885CYP1A2 67/4885CYP3A4 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.